Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
about
The Role of Hedgehog Signaling in Tumor Induced Bone DiseasePLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitroTargeting tumor metastases: Drug delivery mechanisms and technologies.Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma.A novel double-targeted nondrug delivery system for targeting cancer stem cells.Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapyNanoparticles for imaging and treatment of metastatic breast cancer.Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.Nanocarrier based approaches for targeting breast cancer stem cells.A new strategy for the passive skin delivery of nanoparticulate, high molecular weight hyaluronic acid prepared by a polyion complex method.Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance.Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption.Triple Redox Responsive Poly(Ethylene Glycol)-Polycaprolactone Polymeric Nanocarriers for Fine-Controlled Drug Release.A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effectsGlutathione responsive polymers and their application in drug delivery systemsPLGA-Based Nanoparticles in Cancer TreatmentUsing a peptide segment to covalently conjugate doxorubicin and taxol for the study of drug combination effect
P2860
Q26783615-C62FB147-2E7D-467F-A5FE-12CE49ACDBF7Q27348681-898B762D-4102-4DBC-A594-8C1BA901AFFCQ36557855-2B02ADAC-CCA6-4AF6-93C9-F9528976F7E2Q37241907-B704C485-F6E0-4B23-8EDC-30303122C1E5Q37500094-EBBAB0D1-FF73-4292-BABD-17FE44C3CCFCQ38823095-612A5F64-63AC-439A-8ADD-7AE5CAFD37ECQ38842983-4CB6F5CD-A6C5-4D3C-A874-B50431493DFFQ38928173-B5EED569-04E6-461E-A94E-379507981732Q42658800-A84A704A-18B5-49A8-86AB-606ED2719F8CQ47108689-95D75F65-4E9E-4777-93E4-3249DEA5234DQ48209273-FCD12A30-41E5-4CBF-BBD0-820B97D758D0Q48512429-44F02FEB-596D-4EAC-9467-D176B0C968C6Q49788112-6177E281-F537-456B-99EC-B9651DC46A87Q50648312-1E4840FF-42AC-4A4C-98BD-7F1AB8ABB2D7Q53563682-37EC3C11-513F-4304-93CA-93016215EC74Q57169252-7937E8AB-699E-4A98-9EFF-7B506D085787Q57367081-B8998F06-6C81-40AB-AE17-CBE9AC8B2A73Q59137460-E2088BC5-0E8D-400F-A44C-9D9008981B25Q59279594-8638627D-9351-4267-AD54-94798C92B58C
P2860
Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Hyaluronic acid functional amp ...... r cells and cancer stem cells.
@en
type
label
Hyaluronic acid functional amp ...... r cells and cancer stem cells.
@en
prefLabel
Hyaluronic acid functional amp ...... r cells and cancer stem cells.
@en
P2093
P2860
P356
P1433
P1476
Hyaluronic acid functional amp ...... er cells and cancer stem cells
@en
P2093
Chunying Chen
Huige Zhou
Jiakun Zhang
Jiayang Li
Wang Sheng
Yuliang Zhao
P2860
P304
P356
10.1039/C5NR01084E
P407
P577
2015-05-01T00:00:00Z